chr12-63802265-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_014254.3(RXYLT1):​c.603C>A​(p.Leu201Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. L201L) has been classified as Benign.

Frequency

Genomes: not found (cov: 31)

Consequence

RXYLT1
NM_014254.3 synonymous

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.412

Publications

0 publications found
Variant links:
Genes affected
RXYLT1 (HGNC:13530): (ribitol xylosyltransferase 1) This gene encodes a type II transmembrane protein that is thought to have glycosyltransferase function. Mutations in this gene result in cobblestone lissencephaly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
RXYLT1 Gene-Disease associations (from GenCC):
  • muscle-eye-brain disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Genomics England PanelApp
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014254.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RXYLT1
NM_014254.3
MANE Select
c.603C>Ap.Leu201Leu
synonymous
Exon 4 of 6NP_055069.1Q9Y2B1
RXYLT1
NM_001278237.2
c.-178C>A
5_prime_UTR
Exon 4 of 6NP_001265166.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RXYLT1
ENST00000261234.11
TSL:1 MANE Select
c.603C>Ap.Leu201Leu
synonymous
Exon 4 of 6ENSP00000261234.6Q9Y2B1
RXYLT1
ENST00000537373.6
TSL:1
n.*338C>A
non_coding_transcript_exon
Exon 4 of 6ENSP00000440280.2G3V1K2
RXYLT1
ENST00000537373.6
TSL:1
n.*338C>A
3_prime_UTR
Exon 4 of 6ENSP00000440280.2G3V1K2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
31

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
1.9
DANN
Benign
0.71
PhyloP100
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.72
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.72
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

hg19: chr12-64196045; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.